Press releases 9 March 2017 Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia Partnership Therapeutic areas
Press releases 5 January 2017 Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance Partnership Therapeutic areas
